Physician profile
Robert D Prock
NPI 1457359309
$411.83
in general payments reported to CMS, 2019-2025
10 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.58 · 2022: $17.05 · 2023: $115 · 2024: $53.57 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $114.61 | 2019-2024 | Imfinzi |
| Ethicon INC. | $99.06 | 2025 | Monarch Platform |
| Sumitomo Pharma America, INC. | $54.01 | 2023-2024 | Orgovyx |
| Teleflex LLC | $32.21 | 2025 | Barrigel |
| Medtronic USA, INC. | $23.60 | 2019 | |
| Siemens Medical Solutions USA, INC. | $20.69 | 2025 | Truebeam |
| Angiodynamics, INC. | $19.28 | 2019 | |
| Merck Sharp & Dohme LLC | $18.35 | 2023 | Keytruda |
| Regeneron Healthcare Solutions, INC. | $17.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Prock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.